Related Experiment Videos
[Value of diuretics in hypertension]
1Klinischen Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Wien.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1996
Summary
Low-dose diuretic therapy, particularly indapamide, is recommended for hypertension management to minimize adverse metabolic effects. Indapamide shows advantages over hydrochlorothiazide in patients with diabetes and chronic renal failure.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Diuretics are essential for hypertension treatment.
- Adverse effects like metabolic disturbances and electrolyte imbalances are dose-dependent.
- Low-dose therapy is increasingly favored.
Purpose of the Study:
- To compare the efficacy and safety of indapamide versus hydrochlorothiazide in hypertension management.
- To evaluate the impact of these diuretics on metabolic parameters and renal function.
Main Methods:
- Review of existing literature on diuretic therapy for hypertension.
- Comparative analysis of indapamide and hydrochlorothiazide, focusing on adverse effects and specific patient populations.
Main Results:
- Indapamide is associated with fewer metabolic disorders compared to hydrochlorothiazide.
- Combined diuretic therapy enhances efficacy by targeting different nephron segments.
- Indapamide demonstrates superiority in preserving renal function in chronic renal failure.
- Indapamide is preferred over thiazides for diabetic patients.
Conclusions:
- Low-dose indapamide therapy offers a favorable risk-benefit profile for hypertension.
- Indapamide is a suitable option for hypertensive patients with diabetes and chronic kidney disease.